{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": [
                {
                    "patient": "Case 1",
                    "findings": "Hypercalcemia, hypercalciuria, nephrocalcinosis, suppressed serum PTH, elevated serum 1,25-dihydroxyvitamin D3, reduced renal function with serum creatinine of 1.4 mg/dL."
                },
                {
                    "patient": "Case 2",
                    "findings": "Hypercalcemia with albumin-adjusted calcium of 12.8 mg/dL, hypercalciuria with urinary calcium/creatinine ratio of 0.59 mg/mg, and suppressed serum PTH at 4 pg/mL."
                }
            ],
            "changes_over_time": [
                {
                    "patient": "Case 1",
                    "changes": "Within 1 month of treatment, marked improvement with reduction in serum 1,25-dihydroxyvitamin D3 and calcium, increasing PTH into normal range, and serum creatinine improved to 1.1 mg/dL."
                },
                {
                    "patient": "Case 2",
                    "changes": "Serum albumin-adjusted calcium declined from 10.7 to 9.8 mg/dL; PTH concentration increased from 3 to 31 pg/mL. After 1 month of discontinuation of rifampin, serum and urinary calcium levels increased, 1,25-dihydroxyvitamin D3 rose from 58 to 90 pg/mL, and PTH was suppressed again."
                }
            ]
        }
    ]
}